Alkermes plc

Filed a patent for "crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia" on Thu, July 25, 2024

Filed a patent for "aripiprazole formulations having increased injection speeds" on Thu, January 26, 2023

Filed a patent for "methods of administering intravenous meloxicam in a bolus dose" on Thu, September 28, 2023

Filed a patent for "heterocyclic compounds for the treatment of neurological and psychological disorders" on Thu, May 18, 2023

Filed a patent for "interleukin 18 variants" on Fri, November 11, 2022

Filed a patent for "immediate release multilayer tablet" on Thu, October 5, 2023

Filed a patent for "immunostimulatory agents in combination with angiogenesis inhibitors" on Thu, May 16, 2024

Filed a patent for "interleukin 18 variants" on Thu, June 6, 2024

Filed a patent for "pharmaceutical compositions comprising sorbitan esters" on Thu, April 25, 2024

Filed a patent for "immediate release multilayer tablet" on Thu, March 21, 2024

Filed a patent for "immediate release multilayer tablet" on Thu, March 14, 2024

Filed a patent for "immediate release multilayer tablet" on Thu, November 10, 2022